ASLAN Pharmaceuticals Limited (ASLN) Social Stream
ASLAN PHARMACEUTICALS LTD (ASLN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering ASLAN PHARMACEUTICALS LTD.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-05-23 | 3 | $8 | $3 | $6.333 | $0.525 | 1106.29% |
| 2022-08-12 | 2 | $8 | $3 | $6.333 | $0.525 | 1106.29% |
| 2022-09-08 | 2 | $8 | $3 | $6 | $0.525 | 1042.86% |
| 2022-09-16 | 2 | $8 | $4 | $6.333 | $0.525 | 1106.29% |
| 2022-09-29 | 3 | $8 | $4 | $6.333 | $0.525 | 1106.29% |
| 2023-01-03 | 3 | $7 | $4 | $5.5 | $0.525 | 947.62% |
| 2023-03-01 | 3 | $4.5 | $3 | $3.75 | $0.525 | 614.29% |
| 2023-03-13 | 3 | $22.5 | $15 | $18.75 | $0.525 | 3471.43% |
| 2023-03-27 | 3 | $20 | $15 | $17.5 | $0.525 | 3233.33% |
| 2023-05-15 | 4 | $17 | $15 | $16 | $0.525 | 2947.62% |
| 2023-10-30 | 4 | $17 | $15 | $15.666 | $0.525 | 2884% |
The Trend in the Analyst Price Target
Over the past 42 months, ASLN's average price target has gone up $10.17.
ASLN reports an average of 670.38% for its upside potential over the past 35 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-27 | 3 | 4.5 | 3 | 3.750 | 3.945 | -4.94% |
| 2023-03-13 | 3 | 22.5 | 15 | 18.750 | 2.560 | 632.42% |
| 2023-05-31 | 4 | 17.0 | 15 | 15.666 | 4.000 | 291.65% |
| 2023-10-16 | 4 | 17.0 | 15 | 15.666 | 1.290 | 1114.42% |
| 2023-10-30 | 3 | 17.0 | 15 | 15.666 | 1.140 | 1274.21% |
ASLN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ASLN's average broker recommendation rating improved by 0 over the prior 26 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ASLN as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, ASLAN PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is greater than 1274.08% of them.
- ASLAN PHARMACEUTICALS LTD's number of analysts covering the stock is greater than 94.23% of all US stocks.
- ASLAN PHARMACEUTICALS LTD's average analyst price target is higher than 222.65% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, ASLAN PHARMACEUTICALS LTD's variance in analysts' estimates is lower than -279.72% of them.
Stocks similar to ASLAN PHARMACEUTICALS LTD in the Pharmaceutical Products industry regarding analyst recommendations and price targets are COCP, ENVB, and EYEN.
View All Top Stocks by Price Target
Is ASLN a Buy, Hold or Sell? See the POWR Ratings now!